Skip to main content

Live ResMed Inc. Share Price Chart

O H L

ResMed Inc. Performance Overview

Days Range
▼
$218.32Low
$223.69High

Markets Today

Previous Close$221.15
Open$222.83
Volume845,480
Day's Range$218.32 - $223.69
52W Range$180.26 - $284.87
Market Cap$31.90 B

Historical Performance

1M Returns-4.49
3M Returns+4.42
6M Returns-2.32
1Y Returns-21.43
5Y Returns-14.17
10Y Returns+240.26

ResMed Inc. Fundamentals

Market Cap$31.90 B
Dividend yield1.19
PE Ratio21.19
PEG RatioN/A
Revenue$5.65 B
ROE TTM0.24
EPS TTM$10.44
Quarterly Earnings Growth YOYN/A
PB Ratio4.84
EBITDA$2.11 B
Profit Margin26.94
Market Cap$31.90 B
Dividend yield1.19
PE Ratio21.19
PEG RatioN/A
Revenue$5.65 B
ROE TTM0.24
EPS TTM$10.44
Quarterly Earnings Growth YOYN/A
PB Ratio4.84
EBITDA$2.11 B
Profit Margin26.94

ResMed Inc. Profit & Loss

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Total Revenue +$1.29 B$1.35 B$1.34 B$1.42 B$1.43 B$1.46 B
Gross Profit +$773.85 M$829.44 M$828.64 M$886.53 M$898.83 M$869.52 M
Operating Income $426.27 M$454.54 M$446.54 M$491.66 M$499.81 M$448.71 M
EBITDA $469.94 M$518.17 M$510.05 M$547.48 M$558.79 M$493.49 M
Interest Expense $793.00 K$5.76 M$0$0$12.29 M$20.89 M
Depreciation $43.68 M$63.63 M$63.51 M$55.82 M$58.98 M$44.78 M
Income Before Tax $417.69 M$458.05 M$446.79 M$496.15 M$502.31 M$474.16 M
Income Tax Expense $52.65 M$78.35 M$98.26 M$103.56 M$103.58 M$90.73 M
Net Income +$365.04 M$379.70 M$348.54 M$392.59 M$398.73 M$383.43 M
Net Profit Margin 28.26%28.17%26.1%27.59%27.86%26.2%

ResMed Inc. Financials Balance Sheet In USD

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Share Capital $761.00 K$761.00 K$762.00 K$763.00 K$763.00 K$764.00 K
Reserve & Surplus $5.53 B$6.01 B$6.28 B$6.62 B$6.93 B$7.17 B
Non-Current Liabilities $1.08 B$1.19 B$931.59 M$934.38 M$941.16 M$985.45 M
Current Liabilities $940.52 M$1.02 B$1.26 B$1.25 B$1.35 B$1.35 B
Total Liabilities $2.02 B$2.21 B$2.19 B$2.18 B$2.29 B$2.38 B
Fixed Assets $965.45 M$1.02 B$1.01 B$994.49 M$992.16 M$1.03 B
Current Assets $3.21 B$3.51 B$3.63 B$3.82 B$4.06 B$4.32 B
Total Assets $7.57 B$8.17 B$8.31 B$8.50 B$8.78 B$8.97 B

ResMed Inc. Cash Flow

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Net Income $365.04 M$379.70 M$348.54 M$392.59 M$398.73 M$383.43 M
Operating Cash Flow $578.66 M$538.77 M$457.32 M$339.75 M$554.13 M$454.63 M
Investing Cash Flow -$31.79 M-$133.71 M-$52.58 M-$50.94 M-$58.03 M-$383.65 M
Financing Cash Flow -$144.07 M-$163.89 M-$230.27 M-$258.35 M-$255.24 M-$263.16 M
Change in Cash $410.77 M$276.74 M$174.40 M$33.22 M$243.44 M-$191.28 M

ResMed Inc. Peer Comparison

CompanyMarket Cap5 Years Return %PE RatioProfit Margin %Dividend Yield %
MEDP
$16.69B213.04%35.0817.83%0.00%
HIMS
$6.84B300.55%0.005.47%0.00%
EHC
$11.75B63.13%19.9412.79%0.71%

ResMed Inc. Return Calculator

The ResMed Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Returns Estimator

Based on past performance of this fund

ENTER AMOUNT
$10,000
Select Duration
5Yrs
1 Yr5 Yrs
If you had invested $10,000 5 years ago, what would its value be today?$8,313
Invested Amount$10,000
Est. Returns$-1,687
Invest in USA Stock Today

About ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

FAQs

ResMed Inc. (RMD) share price as of October 3, 2026 is $212.00. If you are investing from India, you can always check the valuation in the INR before investing.
Yes, Indian Investors can invest in the ResMed Inc. (RMD) Share by opening an international trading account with Angel One.
Purchasing ResMed Inc. (RMD) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying ResMed Inc. (RMD) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Yes, you can purchase fractional shares of ResMed Inc. (RMD) or any other US company shares in Angel One for any dollar amount.
The market capitalization of ResMed Inc. on October 3, 2026, is $31.90 B.
ResMed Inc. operates in the Healthcare sector, specifically in the Healthcare industry.
In order to invest in ResMed Inc. (RMD) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.

Diversify Your Portfolio with US Stocks

Invest in Wall Street Giants from India

+91
Top US Stocks

VIEW ALL